Trademark: 97446056
Word
GSK
Status
Pending
Status Code
730
Status Date
Wednesday, March 6, 2024
Serial Number
97446056
Mark Type
5000
Filing Date
Tuesday, June 7, 2022
Published for Opposition
Tuesday, August 8, 2023

Trademark Owner History
SmithKline Beecham Limited - Owner At Publication

Classifications
41 Educational services, namely, conducting classes in the field of pharmaceutical, diagnostic, vaccines, proprietary medicines, health, medical and skin care industries; educational services, namely, conducting seminars regarding health and health awareness and distributing course material in connection therewith; academic education, instruction and training, namely, conducting classes in the field of science, biotechnology, biology, health, health awareness and life sciences; conducting, organizing and arranging conferences, seminars and exhibitions for educational purposes in the field of medicine, health and wellness; publication of documents recorded on electronic storage media and on the internet in the field of scientific, medical diagnostic and technical laboratory matters and for research; training in the operation, repair and maintenance of scientific, surgical and medical devices and apparatus; publishing and issuing of scientific papers in the field of pharmaceuticals, diagnostic, vaccines, proprietary medicines, health, medical and skin care; provision of information, consultancy and advisory services relating to any of the aforesaid services
9 Downloadable computer software for use in enabling healthcare professionals to access information on pharmaceutical and medical related products and services; downloadable computer software programs using artificial intelligence for use in machine learning
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes; medicated and sanitizing soaps and detergents
35 Advertising, marketing and promotional services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; the provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, healthcare and fitness products through an on-line computer network; retail and wholesale store services featuring pharmaceuticals; distribution of advertising, marketing and promotional material
44 Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services
10 Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices sold empty, namely, syringes for medical purposes and for injections; surgical implants comprising artificial material
42 Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting genetic testing for research purposes; scientific research consulting; medical laboratory services; Providing medical and scientific research information; computer system design services in the nature of design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services
The mark consists of stylized letters "GSK" in gradient orange to yellow-orange.
The color(s) orange, yellow is/are claimed as a feature of the mark.

Trademark Events
Mar 7, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2024
Sou Extension 1 Granted
Mar 6, 2024
Sou Extension 1 Filed
Mar 6, 2024
Sou Teas Extension Received
Oct 3, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 8, 2023
Published For Opposition
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Jul 5, 2023
Electronic Record Review Complete
Jun 30, 2023
On Hold - Electronic Record Review Required
Jun 22, 2023
Approved For Pub - Principal Register
Jun 22, 2023
Teas/Email Correspondence Entered
Jun 22, 2023
Correspondence Received In Law Office
Jun 22, 2023
Teas Response To Office Action Received
Mar 24, 2023
Notification Of Non-Final Action E-Mailed
Mar 24, 2023
Non-Final Action E-Mailed
Mar 24, 2023
Non-Final Action Written
Mar 22, 2023
Assigned To Examiner
Aug 2, 2022
Teas Change Of Correspondence Received
Aug 2, 2022
Teas Change Of Domestic Representatives Address
Aug 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 15, 2022
New Application Office Supplied Data Entered
Jun 10, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24